US · Healthcare · Medical Instruments & Supplies
EPS came in at 0.13 against a street estimate of 0.09 — a beat of 46.3%.
Analysts rate MiniMed Group, Inc. Common Stock a buy (11 buy, 2 hold, 1 sell out of 14) with an average price target of $24.64.
| Fund | Stake |
|---|---|
| Massachusetts Financial Services Company | 2.96% |
| Millennium Management LLC | 1.09% |
| Citadel Advisors Llc | 1.02% |
| Longaeva Partners L.P. | 1.00% |
| Sessa Capital, L.P | 0.71% |
| BlackRock Inc | 0.71% |
| NORGES BANK | 0.70% |
| Rock Springs Capital Management LP | 0.54% |
| Document | Date |
|---|---|
| Board / officer change · Q4 2026 HEADLINE NUMBERS • MiniMed completed its exchange offer on October 15, 2026. • Medtronic shareholders exchanged 55,032,401 Medtronic ordinary shares | 2026-10-16 |
| Shareholder vote results · Q4 2026 HEADLINE NUMBERS • MiniMed Group held its 2026 Annual Meeting of Stockholders on October 9, 2026. • All four proposals were approved. • Four Class | 2026-10-13 |
| Quarterly report · Q3 2026 MINIMED GROUP, INC. – Q1 FY2027 10-Q SUMMARY --- HEADLINE NUMBERS • Net sales: $843 million (Q1 FY2027) vs. $723 million (Q1 FY2026) – 16.6% growth | 2026-09-08 |
| Results announced · Q3 2026 MINIMED Q1 FY2027 EARNINGS SUMMARY HEADLINE NUMBERS • Net sales of $843 million, up 17% as reported and 16% organic year-over-year • U.S. net sales | 2026-09-01 |
| Proxy statement · Q4 2026 MINIMED GROUP, INC. – 2026 PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1 (Election of Directors): Vote to elect four Class I | 2026-08-21 |
| Board / officer change · Q3 2026 MINIMED GROUP, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • No financial metrics provided in this filing • Document dated July 30, 2026 (earliest even | 2026-08-05 |
| Annual report FY2026 MINIMED GROUP, INC. – FORM 10-K SUMMARY FOR FISCAL YEAR ENDED APRIL 24, 2026 HEADLINE NUMBERS • Company: MiniMed Group, Inc., traded as MMED on Nasd | 2026-06-29 |
| Board / officer change · Q2 2026 MINIMED GROUP, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Board size increased from 9 to 11 directors (2 new appointments effective June 29, 2026) • | 2026-06-29 |
Readable in the app.
| Announcement | Date |
|---|---|
| Exchange offer completed, resulting in ownership change and board reconstitution MiniMed completed its exchange offer on October 15, 2026. Medtronic shareholders exchanged 55,032,401 Medtronic ordinary shares for 252,813,348 newly issued MiniMed common shares. Medtronic | 2026-10-16 |
| FDA clears next-generation insulin pump for earlier commercialization MiniMed Group announced FDA clearance of its MiniMed Flex, a smartphone-controlled insulin pump, several months ahead of schedule. This is positive for commercialization timing. However, the | 2026-03-25 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for MiniMed Group, Inc. Common Stock — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.